Drug intelligence / Profile preview

Bushenkaiqiao

Development stage
Unknown
Lead developer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Bushenkaiqiao is a Traditional Chinese Medicine (TCM) formula developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine for the treatment of Alzheimer's disease. Based on the TCM principles of tonifying the kidney and opening the orifices, the formula typically comprises several herbal components, including *Herba Epimedii*, *Fructus Psoraleae*, *Rhizoma Acori Tatarinowii*, and *Radix Polygalae*. It is designed to address the cognitive decline associated with aging and neurodegeneration. Research suggests that Bushenkaiqiao exerts neuroprotective effects by reducing amyloid-beta (Aβ) accumulation, inhibiting tau protein hyperphosphorylation, and modulating neuroinflammation and oxidative stress in the brain. It has been evaluated in clinical trials in China, demonstrating potential in improving cognitive function and daily living activities in patients with mild-to-moderate Alzheimer's disease.

Other names
Bushen Kaiqiao FormulaBushen Kaiqiao DecoctionBushen Kaiqiao Capsule
02

Targets

AcetylcholinesteraseAβ (Amyloid-beta peptides and aggregates)MAPT (Microtubule-associated protein tau)

Beyond the preview

Go deeper on Bushenkaiqiao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushenkaiqiao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call